FDA Alert: TNF-blockers can increase the risk of fungal infection
The FDA is concerned that it is not widely enough known that the use of TNF-blockers (used to treat a variety of conditions such as rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, and Crohn's disease) also suppresses the immune systems of patients taking the drug.Patients with a suppressed immune system are more vulnerable to
0 Response to "FDA Alert: TNF-blockers can increase the risk of fungal infection"
Post a Comment